Evaluation of anti-HIV activity of 5- (2-phenyl-3′-indolal)-2-thiohydantoin
- 1 July 1998
- journal article
- research article
- Published by Elsevier in Il Farmaco
- Vol. 53 (7) , 525-527
- https://doi.org/10.1016/s0014-827x(98)00053-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Tetrahydronaphthalene Lignan Compounds as Potent Anti-HIV Type 1 AgentsAIDS Research and Human Retroviruses, 1997
- HIV Inhibitors Targeted at the Reverse TranscriptaseAIDS Research and Human Retroviruses, 1992
- Inhibition of human immunodeficiency virus 1 reverse transcriptase by 3'-azidothymidine triphosphateEuropean Journal of Biochemistry, 1990
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990
- Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivativeBiochemical and Biophysical Research Communications, 1989
- Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)Science, 1989
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Development of Antiretroviral Therapy for the Acquired Immunodeficiency Syndrome and Related DisordersNew England Journal of Medicine, 1987
- Strategies for antiviral therapy in AIDSNature, 1987
- Inhibition of reverse transcriptase activity by 2′,3′-dideoxythymidine 5′-triphosphate and its derivatives modified on the 3′ positionBiochemical and Biophysical Research Communications, 1986